The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Congenital Heart Disease Treatment Device Market Research Report 2024
Synopsis
Congenital heart disease (CHD) is a cardiovascular malformation caused by abnormal fetal heart and blood vessel development, and it is one of the most common congenital malformations.
The global Congenital Heart Disease Treatment Device market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Congenital Heart Disease Treatment Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Congenital Heart Disease Treatment Device.
Report Scope
The Congenital Heart Disease Treatment Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Congenital Heart Disease Treatment Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Congenital Heart Disease Treatment Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Medtronic plc
Beijing Balance Medical Technology
Med-Zenith
MicroPort
Weigao Holding Company Limited
CryoLife
Edwards LifeSciences
Segment by Type
Artificial Heart Valve
Bracket
Ventricular Assist Device (VAD)
Other
Segment by Application
Adult
Children
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Congenital Heart Disease Treatment Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Congenital Heart Disease Treatment Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Congenital heart disease (CHD) is a cardiovascular malformation caused by abnormal fetal heart and blood vessel development, and it is one of the most common congenital malformations.
The global Congenital Heart Disease Treatment Device market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Congenital Heart Disease Treatment Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Congenital Heart Disease Treatment Device.
Report Scope
The Congenital Heart Disease Treatment Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Congenital Heart Disease Treatment Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Congenital Heart Disease Treatment Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Medtronic plc
Beijing Balance Medical Technology
Med-Zenith
MicroPort
Weigao Holding Company Limited
CryoLife
Edwards LifeSciences
Segment by Type
Artificial Heart Valve
Bracket
Ventricular Assist Device (VAD)
Other
Segment by Application
Adult
Children
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Congenital Heart Disease Treatment Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Congenital Heart Disease Treatment Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Congenital Heart Disease Treatment Device Market Overview
1.1 Product Overview and Scope of Congenital Heart Disease Treatment Device
1.2 Congenital Heart Disease Treatment Device Segment by Type
1.2.1 Global Congenital Heart Disease Treatment Device Market Value Comparison by Type (2024-2030)
1.2.2 Artificial Heart Valve
1.2.3 Bracket
1.2.4 Ventricular Assist Device (VAD)
1.2.5 Other
1.3 Congenital Heart Disease Treatment Device Segment by Application
1.3.1 Global Congenital Heart Disease Treatment Device Market Value by Application: (2024-2030)
1.3.2 Adult
1.3.3 Children
1.4 Global Congenital Heart Disease Treatment Device Market Size Estimates and Forecasts
1.4.1 Global Congenital Heart Disease Treatment Device Revenue 2019-2030
1.4.2 Global Congenital Heart Disease Treatment Device Sales 2019-2030
1.4.3 Global Congenital Heart Disease Treatment Device Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Congenital Heart Disease Treatment Device Market Competition by Manufacturers
2.1 Global Congenital Heart Disease Treatment Device Sales Market Share by Manufacturers (2019-2024)
2.2 Global Congenital Heart Disease Treatment Device Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Congenital Heart Disease Treatment Device Average Price by Manufacturers (2019-2024)
2.4 Global Congenital Heart Disease Treatment Device Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Congenital Heart Disease Treatment Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Congenital Heart Disease Treatment Device, Product Type & Application
2.7 Congenital Heart Disease Treatment Device Market Competitive Situation and Trends
2.7.1 Congenital Heart Disease Treatment Device Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Congenital Heart Disease Treatment Device Players Market Share by Revenue
2.7.3 Global Congenital Heart Disease Treatment Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Congenital Heart Disease Treatment Device Retrospective Market Scenario by Region
3.1 Global Congenital Heart Disease Treatment Device Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Congenital Heart Disease Treatment Device Global Congenital Heart Disease Treatment Device Sales by Region: 2019-2030
3.2.1 Global Congenital Heart Disease Treatment Device Sales by Region: 2019-2024
3.2.2 Global Congenital Heart Disease Treatment Device Sales by Region: 2025-2030
3.3 Global Congenital Heart Disease Treatment Device Global Congenital Heart Disease Treatment Device Revenue by Region: 2019-2030
3.3.1 Global Congenital Heart Disease Treatment Device Revenue by Region: 2019-2024
3.3.2 Global Congenital Heart Disease Treatment Device Revenue by Region: 2025-2030
3.4 North America Congenital Heart Disease Treatment Device Market Facts & Figures by Country
3.4.1 North America Congenital Heart Disease Treatment Device Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Congenital Heart Disease Treatment Device Sales by Country (2019-2030)
3.4.3 North America Congenital Heart Disease Treatment Device Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Congenital Heart Disease Treatment Device Market Facts & Figures by Country
3.5.1 Europe Congenital Heart Disease Treatment Device Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Congenital Heart Disease Treatment Device Sales by Country (2019-2030)
3.5.3 Europe Congenital Heart Disease Treatment Device Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Congenital Heart Disease Treatment Device Market Facts & Figures by Country
3.6.1 Asia Pacific Congenital Heart Disease Treatment Device Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Congenital Heart Disease Treatment Device Sales by Country (2019-2030)
3.6.3 Asia Pacific Congenital Heart Disease Treatment Device Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Congenital Heart Disease Treatment Device Market Facts & Figures by Country
3.7.1 Latin America Congenital Heart Disease Treatment Device Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Congenital Heart Disease Treatment Device Sales by Country (2019-2030)
3.7.3 Latin America Congenital Heart Disease Treatment Device Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Congenital Heart Disease Treatment Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Congenital Heart Disease Treatment Device Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Congenital Heart Disease Treatment Device Sales by Country (2019-2030)
3.8.3 Middle East and Africa Congenital Heart Disease Treatment Device Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Congenital Heart Disease Treatment Device Sales by Type (2019-2030)
4.1.1 Global Congenital Heart Disease Treatment Device Sales by Type (2019-2024)
4.1.2 Global Congenital Heart Disease Treatment Device Sales by Type (2025-2030)
4.1.3 Global Congenital Heart Disease Treatment Device Sales Market Share by Type (2019-2030)
4.2 Global Congenital Heart Disease Treatment Device Revenue by Type (2019-2030)
4.2.1 Global Congenital Heart Disease Treatment Device Revenue by Type (2019-2024)
4.2.2 Global Congenital Heart Disease Treatment Device Revenue by Type (2025-2030)
4.2.3 Global Congenital Heart Disease Treatment Device Revenue Market Share by Type (2019-2030)
4.3 Global Congenital Heart Disease Treatment Device Price by Type (2019-2030)
5 Segment by Application
5.1 Global Congenital Heart Disease Treatment Device Sales by Application (2019-2030)
5.1.1 Global Congenital Heart Disease Treatment Device Sales by Application (2019-2024)
5.1.2 Global Congenital Heart Disease Treatment Device Sales by Application (2025-2030)
5.1.3 Global Congenital Heart Disease Treatment Device Sales Market Share by Application (2019-2030)
5.2 Global Congenital Heart Disease Treatment Device Revenue by Application (2019-2030)
5.2.1 Global Congenital Heart Disease Treatment Device Revenue by Application (2019-2024)
5.2.2 Global Congenital Heart Disease Treatment Device Revenue by Application (2025-2030)
5.2.3 Global Congenital Heart Disease Treatment Device Revenue Market Share by Application (2019-2030)
5.3 Global Congenital Heart Disease Treatment Device Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Corporation Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Congenital Heart Disease Treatment Device Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Abbott Congenital Heart Disease Treatment Device Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Medtronic plc
6.2.1 Medtronic plc Corporation Information
6.2.2 Medtronic plc Description and Business Overview
6.2.3 Medtronic plc Congenital Heart Disease Treatment Device Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Medtronic plc Congenital Heart Disease Treatment Device Product Portfolio
6.2.5 Medtronic plc Recent Developments/Updates
6.3 Beijing Balance Medical Technology
6.3.1 Beijing Balance Medical Technology Corporation Information
6.3.2 Beijing Balance Medical Technology Description and Business Overview
6.3.3 Beijing Balance Medical Technology Congenital Heart Disease Treatment Device Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Beijing Balance Medical Technology Congenital Heart Disease Treatment Device Product Portfolio
6.3.5 Beijing Balance Medical Technology Recent Developments/Updates
6.4 Med-Zenith
6.4.1 Med-Zenith Corporation Information
6.4.2 Med-Zenith Description and Business Overview
6.4.3 Med-Zenith Congenital Heart Disease Treatment Device Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Med-Zenith Congenital Heart Disease Treatment Device Product Portfolio
6.4.5 Med-Zenith Recent Developments/Updates
6.5 MicroPort
6.5.1 MicroPort Corporation Information
6.5.2 MicroPort Description and Business Overview
6.5.3 MicroPort Congenital Heart Disease Treatment Device Sales, Revenue and Gross Margin (2019-2024)
6.5.4 MicroPort Congenital Heart Disease Treatment Device Product Portfolio
6.5.5 MicroPort Recent Developments/Updates
6.6 Weigao Holding Company Limited
6.6.1 Weigao Holding Company Limited Corporation Information
6.6.2 Weigao Holding Company Limited Description and Business Overview
6.6.3 Weigao Holding Company Limited Congenital Heart Disease Treatment Device Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Weigao Holding Company Limited Congenital Heart Disease Treatment Device Product Portfolio
6.6.5 Weigao Holding Company Limited Recent Developments/Updates
6.7 CryoLife
6.6.1 CryoLife Corporation Information
6.6.2 CryoLife Description and Business Overview
6.6.3 CryoLife Congenital Heart Disease Treatment Device Sales, Revenue and Gross Margin (2019-2024)
6.4.4 CryoLife Congenital Heart Disease Treatment Device Product Portfolio
6.7.5 CryoLife Recent Developments/Updates
6.8 Edwards LifeSciences
6.8.1 Edwards LifeSciences Corporation Information
6.8.2 Edwards LifeSciences Description and Business Overview
6.8.3 Edwards LifeSciences Congenital Heart Disease Treatment Device Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Edwards LifeSciences Congenital Heart Disease Treatment Device Product Portfolio
6.8.5 Edwards LifeSciences Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Congenital Heart Disease Treatment Device Industry Chain Analysis
7.2 Congenital Heart Disease Treatment Device Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Congenital Heart Disease Treatment Device Production Mode & Process
7.4 Congenital Heart Disease Treatment Device Sales and Marketing
7.4.1 Congenital Heart Disease Treatment Device Sales Channels
7.4.2 Congenital Heart Disease Treatment Device Distributors
7.5 Congenital Heart Disease Treatment Device Customers
8 Congenital Heart Disease Treatment Device Market Dynamics
8.1 Congenital Heart Disease Treatment Device Industry Trends
8.2 Congenital Heart Disease Treatment Device Market Drivers
8.3 Congenital Heart Disease Treatment Device Market Challenges
8.4 Congenital Heart Disease Treatment Device Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Congenital Heart Disease Treatment Device Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Congenital Heart Disease Treatment Device Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Congenital Heart Disease Treatment Device Market Competitive Situation by Manufacturers in 2023
Table 4. Global Congenital Heart Disease Treatment Device Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Congenital Heart Disease Treatment Device Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Congenital Heart Disease Treatment Device Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Congenital Heart Disease Treatment Device Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Congenital Heart Disease Treatment Device Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Congenital Heart Disease Treatment Device, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Congenital Heart Disease Treatment Device, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Congenital Heart Disease Treatment Device, Product Type & Application
Table 12. Global Key Manufacturers of Congenital Heart Disease Treatment Device, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Congenital Heart Disease Treatment Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Congenital Heart Disease Treatment Device as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Congenital Heart Disease Treatment Device Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Congenital Heart Disease Treatment Device Sales by Region (2019-2024) & (K Units)
Table 18. Global Congenital Heart Disease Treatment Device Sales Market Share by Region (2019-2024)
Table 19. Global Congenital Heart Disease Treatment Device Sales by Region (2025-2030) & (K Units)
Table 20. Global Congenital Heart Disease Treatment Device Sales Market Share by Region (2025-2030)
Table 21. Global Congenital Heart Disease Treatment Device Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Congenital Heart Disease Treatment Device Revenue Market Share by Region (2019-2024)
Table 23. Global Congenital Heart Disease Treatment Device Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Congenital Heart Disease Treatment Device Revenue Market Share by Region (2025-2030)
Table 25. North America Congenital Heart Disease Treatment Device Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Congenital Heart Disease Treatment Device Sales by Country (2019-2024) & (K Units)
Table 27. North America Congenital Heart Disease Treatment Device Sales by Country (2025-2030) & (K Units)
Table 28. North America Congenital Heart Disease Treatment Device Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Congenital Heart Disease Treatment Device Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Congenital Heart Disease Treatment Device Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Congenital Heart Disease Treatment Device Sales by Country (2019-2024) & (K Units)
Table 32. Europe Congenital Heart Disease Treatment Device Sales by Country (2025-2030) & (K Units)
Table 33. Europe Congenital Heart Disease Treatment Device Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Congenital Heart Disease Treatment Device Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Congenital Heart Disease Treatment Device Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Congenital Heart Disease Treatment Device Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Congenital Heart Disease Treatment Device Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Congenital Heart Disease Treatment Device Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Congenital Heart Disease Treatment Device Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Congenital Heart Disease Treatment Device Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Congenital Heart Disease Treatment Device Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Congenital Heart Disease Treatment Device Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Congenital Heart Disease Treatment Device Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Congenital Heart Disease Treatment Device Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Congenital Heart Disease Treatment Device Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Congenital Heart Disease Treatment Device Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Congenital Heart Disease Treatment Device Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Congenital Heart Disease Treatment Device Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Congenital Heart Disease Treatment Device Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Congenital Heart Disease Treatment Device Sales (K Units) by Type (2019-2024)
Table 51. Global Congenital Heart Disease Treatment Device Sales (K Units) by Type (2025-2030)
Table 52. Global Congenital Heart Disease Treatment Device Sales Market Share by Type (2019-2024)
Table 53. Global Congenital Heart Disease Treatment Device Sales Market Share by Type (2025-2030)
Table 54. Global Congenital Heart Disease Treatment Device Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Congenital Heart Disease Treatment Device Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Congenital Heart Disease Treatment Device Revenue Market Share by Type (2019-2024)
Table 57. Global Congenital Heart Disease Treatment Device Revenue Market Share by Type (2025-2030)
Table 58. Global Congenital Heart Disease Treatment Device Price (US$/Unit) by Type (2019-2024)
Table 59. Global Congenital Heart Disease Treatment Device Price (US$/Unit) by Type (2025-2030)
Table 60. Global Congenital Heart Disease Treatment Device Sales (K Units) by Application (2019-2024)
Table 61. Global Congenital Heart Disease Treatment Device Sales (K Units) by Application (2025-2030)
Table 62. Global Congenital Heart Disease Treatment Device Sales Market Share by Application (2019-2024)
Table 63. Global Congenital Heart Disease Treatment Device Sales Market Share by Application (2025-2030)
Table 64. Global Congenital Heart Disease Treatment Device Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Congenital Heart Disease Treatment Device Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Congenital Heart Disease Treatment Device Revenue Market Share by Application (2019-2024)
Table 67. Global Congenital Heart Disease Treatment Device Revenue Market Share by Application (2025-2030)
Table 68. Global Congenital Heart Disease Treatment Device Price (US$/Unit) by Application (2019-2024)
Table 69. Global Congenital Heart Disease Treatment Device Price (US$/Unit) by Application (2025-2030)
Table 70. Abbott Corporation Information
Table 71. Abbott Description and Business Overview
Table 72. Abbott Congenital Heart Disease Treatment Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Abbott Congenital Heart Disease Treatment Device Product
Table 74. Abbott Recent Developments/Updates
Table 75. Medtronic plc Corporation Information
Table 76. Medtronic plc Description and Business Overview
Table 77. Medtronic plc Congenital Heart Disease Treatment Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Medtronic plc Congenital Heart Disease Treatment Device Product
Table 79. Medtronic plc Recent Developments/Updates
Table 80. Beijing Balance Medical Technology Corporation Information
Table 81. Beijing Balance Medical Technology Description and Business Overview
Table 82. Beijing Balance Medical Technology Congenital Heart Disease Treatment Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Beijing Balance Medical Technology Congenital Heart Disease Treatment Device Product
Table 84. Beijing Balance Medical Technology Recent Developments/Updates
Table 85. Med-Zenith Corporation Information
Table 86. Med-Zenith Description and Business Overview
Table 87. Med-Zenith Congenital Heart Disease Treatment Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Med-Zenith Congenital Heart Disease Treatment Device Product
Table 89. Med-Zenith Recent Developments/Updates
Table 90. MicroPort Corporation Information
Table 91. MicroPort Description and Business Overview
Table 92. MicroPort Congenital Heart Disease Treatment Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. MicroPort Congenital Heart Disease Treatment Device Product
Table 94. MicroPort Recent Developments/Updates
Table 95. Weigao Holding Company Limited Corporation Information
Table 96. Weigao Holding Company Limited Description and Business Overview
Table 97. Weigao Holding Company Limited Congenital Heart Disease Treatment Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Weigao Holding Company Limited Congenital Heart Disease Treatment Device Product
Table 99. Weigao Holding Company Limited Recent Developments/Updates
Table 100. CryoLife Corporation Information
Table 101. CryoLife Description and Business Overview
Table 102. CryoLife Congenital Heart Disease Treatment Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. CryoLife Congenital Heart Disease Treatment Device Product
Table 104. CryoLife Recent Developments/Updates
Table 105. Edwards LifeSciences Corporation Information
Table 106. Edwards LifeSciences Description and Business Overview
Table 107. Edwards LifeSciences Congenital Heart Disease Treatment Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Edwards LifeSciences Congenital Heart Disease Treatment Device Product
Table 109. Edwards LifeSciences Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Congenital Heart Disease Treatment Device Distributors List
Table 113. Congenital Heart Disease Treatment Device Customers List
Table 114. Congenital Heart Disease Treatment Device Market Trends
Table 115. Congenital Heart Disease Treatment Device Market Drivers
Table 116. Congenital Heart Disease Treatment Device Market Challenges
Table 117. Congenital Heart Disease Treatment Device Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Congenital Heart Disease Treatment Device
Figure 2. Global Congenital Heart Disease Treatment Device Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Congenital Heart Disease Treatment Device Market Share by Type in 2023 & 2030
Figure 4. Artificial Heart Valve Product Picture
Figure 5. Bracket Product Picture
Figure 6. Ventricular Assist Device (VAD) Product Picture
Figure 7. Other Product Picture
Figure 8. Global Congenital Heart Disease Treatment Device Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Congenital Heart Disease Treatment Device Market Share by Application in 2023 & 2030
Figure 10. Adult
Figure 11. Children
Figure 12. Global Congenital Heart Disease Treatment Device Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Congenital Heart Disease Treatment Device Market Size (2019-2030) & (US$ Million)
Figure 14. Global Congenital Heart Disease Treatment Device Sales (2019-2030) & (K Units)
Figure 15. Global Congenital Heart Disease Treatment Device Average Price (US$/Unit) & (2019-2030)
Figure 16. Congenital Heart Disease Treatment Device Report Years Considered
Figure 17. Congenital Heart Disease Treatment Device Sales Share by Manufacturers in 2023
Figure 18. Global Congenital Heart Disease Treatment Device Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Congenital Heart Disease Treatment Device Players: Market Share by Revenue in 2023
Figure 20. Congenital Heart Disease Treatment Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Congenital Heart Disease Treatment Device Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Congenital Heart Disease Treatment Device Sales Market Share by Country (2019-2030)
Figure 23. North America Congenital Heart Disease Treatment Device Revenue Market Share by Country (2019-2030)
Figure 24. United States Congenital Heart Disease Treatment Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Congenital Heart Disease Treatment Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Congenital Heart Disease Treatment Device Sales Market Share by Country (2019-2030)
Figure 27. Europe Congenital Heart Disease Treatment Device Revenue Market Share by Country (2019-2030)
Figure 28. Germany Congenital Heart Disease Treatment Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Congenital Heart Disease Treatment Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Congenital Heart Disease Treatment Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Congenital Heart Disease Treatment Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Congenital Heart Disease Treatment Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Congenital Heart Disease Treatment Device Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Congenital Heart Disease Treatment Device Revenue Market Share by Region (2019-2030)
Figure 35. China Congenital Heart Disease Treatment Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Congenital Heart Disease Treatment Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Congenital Heart Disease Treatment Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Congenital Heart Disease Treatment Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Congenital Heart Disease Treatment Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Congenital Heart Disease Treatment Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Congenital Heart Disease Treatment Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Congenital Heart Disease Treatment Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Congenital Heart Disease Treatment Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Congenital Heart Disease Treatment Device Sales Market Share by Country (2019-2030)
Figure 45. Latin America Congenital Heart Disease Treatment Device Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Congenital Heart Disease Treatment Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Congenital Heart Disease Treatment Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Congenital Heart Disease Treatment Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Congenital Heart Disease Treatment Device Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Congenital Heart Disease Treatment Device Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Congenital Heart Disease Treatment Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Congenital Heart Disease Treatment Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Congenital Heart Disease Treatment Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Congenital Heart Disease Treatment Device by Type (2019-2030)
Figure 55. Global Revenue Market Share of Congenital Heart Disease Treatment Device by Type (2019-2030)
Figure 56. Global Congenital Heart Disease Treatment Device Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Congenital Heart Disease Treatment Device by Application (2019-2030)
Figure 58. Global Revenue Market Share of Congenital Heart Disease Treatment Device by Application (2019-2030)
Figure 59. Global Congenital Heart Disease Treatment Device Price (US$/Unit) by Application (2019-2030)
Figure 60. Congenital Heart Disease Treatment Device Value Chain
Figure 61. Congenital Heart Disease Treatment Device Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
